[Therapy of bladder incontinence].
D004967:Estrogens / Q000008:administration & dosage; D005465:Fluorocarbon Polymers / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D009821:Oils / Q000009:adverse effects / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use*; D014550:Urinary Incontinence, Stress / Q000188:drug therapy*
D004967:Estrogens; D005465:Fluorocarbon Polymers; D009821:Oils; D012597:Sclerosing Solutions
Behandlung der Blaseninkontinenz.